06
Mar

Texas biotech ZS Pharma banked a $55 million D round, cash that should help get its Phase III-tested treatment into the hands of regulators and, eventually, onto the market.

…read more

Source: ZS Pharma bags $55M to take its kidney drug to the FDA

    

0 No comments